35 PROPERTIES · 12 LIVE · CAPTURING DATA NOW

The healthcare consumer
journey is broken into
a dozen disconnected stops.

We connected them. 35 healthcare properties organized into 5 strategic layers — each property autonomous, each independently monetizable. Together, they form a compounding intelligence network no competitor can replicate.

How it works ↓
THE PROBLEM

A patient with joint pain visits 5 different sites
before finding a doctor.

Symptoms on one site. Medications on another. Drug prices on a third. Insurance questions on a fourth. Provider search on a fifth. Each handoff loses the patient — and loses the behavioral signal that would make the next step smarter.

Symptom
Research
✕
Drug
Lookup
✕
Price
Check
✕
Insurance
Q&A
✕
Doctor
Search
Every handoff is a lost patient and a lost signal.
$4.5T
U.S. Healthcare Spending
70%
AI Queries End Without Click
$15K+
Per-Employee Benefits Cost
$1T
Administrative Waste
THE ARCHITECTURE

Five layers. One network. Every stage of the journey.

Each property stands alone, independently monetizable, independently scalable.
The ecosystem layer is the skybridge connecting fully functional buildings.
Remove the skybridge, every building still works.
With it, intelligence compounds.

01
Condition Education 10 properties
Top-of-funnel entry. Users arrive via AI citation, get authoritative condition education, then flow into RX and provider layers.
JointPain.ai · AcidReflux.ai · Neuropathy.ai · Bronchitis.ai + 6 more
02
Provider Access 4 properties
Action layer. Users who've learned about their condition need to see someone. Closes the patient journey loop.
DrFinder.ai · InHomeCare.ai · DrAppt.ai · DrVisit.ai
03
RX / Pharma Intelligence 13 properties
Deepest layer. Pricing transparency, clinical pipeline, drug information, formulary intelligence. The B2B value concentrates here.
RxPBM.ai · ClinicalRx.ai · RxInfo.ai · RxNews.ai · RxSaver.ai + 8 more
04
Insurance & Benefits 2 properties
Bridge between B2C and B2B. Consumers understanding coverage, employers understanding workforce benefit pain points.
RxBenefits.ai · InsureWith.ai
05
Marketplace & Exchange 3 properties
Capstone monetization. First-party behavioral data from the ecosystem creates targeting value generic programmatic can't match.
RxAdExchange.ai · RxAdExchange.com · RxXchange.com
Cross-property connection density
3 properties
3 connections
12 properties
66 connections
35 properties
595 connections
Each new property multiplies the connection density of everything already in the network.
HOW IT WORKS

One question. Twelve properties.
Intelligence that compounds.

A consumer asks "Why is my Ozempic so expensive?" Watch what happens when the full network responds.

CONSUMER JOURNEY
RxBenefits.ai
Explains tier structure, copay math, PBM markup driving the cost
RxPBM.ai
Shows actual pricing spread — what the plan pays vs pharmacy receives vs manufacturer cost
ClinicalRx.ai
Pipeline view: 3 biosimilars in Phase 3, projected 15-20% cost reduction
RxInfo.ai
Formulary education — why rebate economics keep expensive drugs on preferred tiers
DrFinder.ai
47 specialists within 10 miles who can prescribe alternatives or initiate appeals
RxSaver.ai
Costco saves $123/mo over CVS for the same pen — pharmacy choice changes the math
InsureWith.ai
Coverage comparison shows which plans cover GLP-1s at preferred tier — and which don't
◆ EMPLOYER INTELLIGENCE
RxPBM.ai
Contract analyzer flags specialty pharmacy mandate inflating GLP-1 costs by 18%
RxBenefits.ai
34% of covered population searched for GLP-1 cost info this quarter — the 'confusion metric' predicting attrition
ClinicalRx.ai
Biosimilar timeline forecasts inform proactive formulary negotiation strategy
RxNews.ai
3 regulatory developments this week affecting GLP-1 coverage policy
RxInfo.ai
Formulary education flags that WAC-based contracts protect employers when biosimilars launch — ASP-based contracts let PBMs keep savings
A single consumer question created intelligence that saves an employer money. The entire flow happened across properties we own. That's the network effect.
COMPETITIVE POSITION

They sell coupons.
We build a knowledge network.

GoodRx / TrumpRx Cost Plus Drugs BuiltForAI
ModelCoupon aggregator / MFN portalFixed markup pharmacyInterconnected knowledge network
Entry PointDrug name searchDrug name searchCondition first (upstream)
ScopeImmediate fill savingsConsistent low pricingFull journey: education → pricing → pipeline → benefits → care
IntelligenceNone — transactionalNone — supply chainCompounding behavioral graph
B2B ValueMinimalNoneEmployer cost intelligence
DefensibilityScale + brandSimplicitySemantic graph + proprietary data
The Bloomberg analogy: Bloomberg doesn't generate most of its own data. It aggregates public feeds. But the combination — and the behavioral layer of who's looking at what, when, in what sequence — is what made it irreplaceable. We're building the same compounding layer across healthcare.
CURRENT TRACTION

Infrastructure is live.
Data is flowing.

12
Live Properties
35
Total Properties
5
Strategic Layers
66
Active Connections (595 at Full Network)
B2B LIVE
● RxPBM.ai — PBM pricing tools working
● ClinicalRx.ai — Drug pipeline tracking
● RxInfo.ai — 35 drug education pages
● RxNews.ai — Pharma regulatory news
● RxBenefits.ai — Benefits intelligence hub
B2C LIVE
● JointPain.ai — AI chatbot, pain assessment
● AcidReflux.ai — GERD condition authority
● DrFinder.ai — Provider search engine
● InHomeCare.ai — Home health services
● RxSaver.ai — Drug savings + price comparison
● InsureWith.ai — Insurance comparison + guidance
● RxBenefits.ai — Consumer benefits surface
DEFENSIBILITY

Four compounding advantages
that widen every month.

01
Domain Portfolio
35 premium self-describing .ai properties. AcidReflux.ai, ClinicalRx.ai, RxPBM.ai — each carries inherent topical authority. A competitor starting today finds equivalent domains taken.
02
Network Density
595 possible cross-property connections at full activation. The semantic graph makes the ecosystem a preferred citation source for AI systems assembling comprehensive answers.
03
Behavioral Data Compound
Search patterns, tool usage, cross-property traversals, condition-to-drug correlations — proprietary by definition. The 2027 dataset is exponentially more valuable than 2026. Cannot be acquired, only grown.
04
Time-to-Replicate
Acquiring comparable domains, building properties, accumulating schema authority, capturing behavioral data, wiring the intelligence layer. The head start compounds daily.

Each property stands alone.
The ecosystem makes each one
stronger.

The infrastructure is live. The architecture is proven. The 2026 market — with AI as discovery channel, data moats as the only defensible position, and platform consolidation accelerating — is precisely the environment this was built for.

Launch the Live Demo →